CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Net sales	$ 80,507	$ 78,357	$ 236,480	$ 266,390
Cost of sales	64,289	72,658	190,832	230,656
Amortization of intangibles	1,043	2,621	3,596	10,425
Gross profit	15,175	3,078	42,052	25,309
Operating expenses (income):
Research and development expenses	7,105	5,807	19,212	16,318
Selling, general and administrative expenses	20,446	17,572	55,460	55,268
Restructuring expenses	1,795	1,782	2,276	2,673
Asset impairment charges	72,510		83,147	49,361
Gain on sale of intangible assets			(3,563)
Total operating expenses	101,856	25,161	156,532	123,620
Operating loss	(86,681)	(22,083)	(114,480)	(98,311)
Other income (expense), net:
Investment income	83	34	574	114
Interest expense	(15,179)	(14,517)	(45,393)	(43,171)
Loss on loan receivable			(6,826)
Other income (expense)	336	303	423	252
Total other expense, net	(14,760)	(14,180)	(51,222)	(42,805)
Loss before income tax	(101,441)	(36,263)	(165,702)	(141,116)
Income tax expense (benefit)	29	(1,365)	95	(2,791)
Net loss	$ (101,470)	$ (34,898)	$ (165,797)	$ (138,325)
Loss per common share (1):
Basic (in dollars per share)	$ (9.84)	$ (3.45)	$ (16.13)	$ (13.74)
Diluted (in dollars per share)	$ (9.84)	$ (3.45)	$ (16.13)	$ (13.74)
Weighted average common shares outstanding (1):
Basic (in shares)	10,311,428	10,125,825	10,279,085	10,065,333
Diluted (in shares)	10,311,428	10,125,825	10,279,085	10,065,333